Mendelspod Podcast
The 21st is the Century of Biology. A radical advancement in the knowledge of basic biology and human disease is transforming our world. We interview the heroes beneath the headlines.
- Update frequency
- every 5 days
- Average duration
- 27 minutes
- Episodes
- 505
- Years Active
- 2014 - 2025
April 2018 with Nathan and Laura: Golden State Killer and the Cancer Prediction Space
After decades on the loose, it’s cool the cops finally caught him. But is it cool how they caught him?
Nathan Pearson and Laura Hercher are back for April’s headlines. AACR had some more good news a…
Nathan Pearson and Laura Hercher are back for April’s headlines. AACR had some more good news a…
00:27:46 |
Tue 01 May 2018
Liquid Biopsy for Infectious Disease with Mickey Kertesz, Karius
Sequencing goes to the world of infectious disease.
This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe
This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe
00:19:45 |
Tue 24 Apr 2018
Nanopore Sequencing and the Future of Cancer Research with Chia-Lin Wei, JAX
We can all recognize that PacBio has laid down the railroad tracks in the frontier of long read sequencing. What many are asking is just how close on their caboose is Oxford Nanopore? And just what…
00:23:24 |
Wed 18 Apr 2018
A New Method for Long Reads: Hanlee Ji of Stanford on Cancer Genomics Tech 2018
Hanlee Ji is the Senior Associate Director of the Stanford Genome Technology Center as well as an oncologist at Stanford. He’s also a clinical geneticist. In other words, he doesn’t need to take of…
00:26:56 |
Tue 10 Apr 2018
March 2018 in Genomics with Nathan & Laura: DTC BRCA and Revisiting All of Us
23andMe steals the headlines yet again.
“If somebody is worried about breast cancer susceptibility in their family, they should certainly not be using this test.”
That’s our monthly commentator and gen…
“If somebody is worried about breast cancer susceptibility in their family, they should certainly not be using this test.”
That’s our monthly commentator and gen…
00:18:09 |
Sun 01 Apr 2018
With More Tools in the Box, Lon Cardon Says We’re in a New Age of Drug Development
“I think the field has just really come to life over the last five or seven years. We’ve got all this sequence data. We’ve got the population data. We’ve got gene editing. I’ve been at this thirt…
00:23:32 |
Wed 21 Mar 2018
Personalized Medicine in the Trump Era with Edward Abrahams
The Personalized Medicine Coalition advocates for a wide group of constituents, including scientists, health care providers, entrepreneurs, payers, and patients. Which is why we’ve often wondered ho…
00:27:45 |
Thu 15 Mar 2018
Eric Schadt and Sema4 Try the Consumer Model with Newborn Screening Panel
"We like to refer to it as consumer initiated, but physician supervised,” says Eric Schadt today when asked if his new test is direct-to-consumer.
Eric is the Dean for Precision Medicine at the Icahn …
Eric is the Dean for Precision Medicine at the Icahn …
00:34:12 |
Tue 06 Mar 2018
February 2018 in Genomics with Nathan & Laura: 23andMe Goes for the Gold, Trump Year One
Booking 26 million viewers, the voice of Warren buffet, the endorsements of Olympians Joey Cheek and Tara Lipinski—this company was going for the gold with their ads during the Olympics this year. O…
00:16:42 |
Thu 01 Mar 2018
State of Sequencing 2018 with Keith Robison, Omics! Omics! Blogger
Sequencing geeks are fresh off the trail from AGBT, and it’s time for our annual look at the sequencing tools space. This year we sit down with the longtime Omics! Omics! blogger, Keith Robison, who…
00:31:47 |
Tue 20 Feb 2018
Direct RNA-Seq Project Shows Nanopore Sequencing Can Reveal New Insights into Basic Biology: Winston Timp, JHU
Nanopore sequencing has arrived. Passing test after test this past year--including one we discuss today--this technology which was being hyped decades ago is delivering on its promise.
Winston Timp j…
Winston Timp j…
00:24:47 |
Tue 06 Feb 2018
January 2018 Review Show with Nathan and Laura: CRISPR vs The Immune System, Biotech Math, and MinION's Big Test
Some stocks are up on news of big biotech mergers, but others are down on hearing of the latest difficulties of gene therapy. One thing’s for sure—blood diseases are where it’s at.
Speaking of the la…
Speaking of the la…
00:24:34 |
Thu 01 Feb 2018
Going Beyond the Liver with RNAi: Chris Anzalone of Arrowhead Pharma
Fifteen years ago, folks in the industry were buzzing about RNAi the way they talk about CRISPR today. Then things went quiet for the technology, at least in the news. Until last year.
In September …
In September …
00:19:09 |
Tue 23 Jan 2018
Vice Chancellor Keith Yamamoto on UCSF’s Role in Medicine Today
A major chapter in the history of medicine has been written by UC San Francisco. They are writing the next for precision medicine.
This is a public episode. If you'd like to discuss this with other …
This is a public episode. If you'd like to discuss this with other …
00:26:05 |
Mon 15 Jan 2018
The Global Business of Reproductive Genetic Testing with Gary Harton, Igenomix
Reproductive testing is one of the hottest fields in which genetics is going mainstream, a field hurdling us rapidly into the future. It’s an area we’ll be following closely in 2018.
Gary Harton serv…
Gary Harton serv…
00:37:57 |
Thu 11 Jan 2018
The State of Genomics 2018 with Nathan, Laura, and Misha
Our first show of the year is an outlook on genomics for 2018. To do this we’re joined by our regular commentators, Nathan Pearson and Laura Hercher, and also by a special guest to mix things up a b…
00:36:41 |
Mon 08 Jan 2018
Sharon Begley of STAT News
Sharon Begley joins us for our last show of the year to look back over some of the year’s top stories. She’s the senior science writer at STAT News where she covers genetics, cancer, neuroscience an…
00:31:25 |
Tue 19 Dec 2017
A New “Middle Way” for Genomics, with Physical Chemist, Yuval Ebenstein
“I love low tech,” says today’s guest.
It’s not your typical catch phrase for 2017. But then today’s guest is not your typical genome scientist.
A professor in the Department of Chemical Physics at T…
It’s not your typical catch phrase for 2017. But then today’s guest is not your typical genome scientist.
A professor in the Department of Chemical Physics at T…
00:27:04 |
Wed 13 Dec 2017
Sara Demy on Biotech CEOs
Our topic today: biotech leadership. What makes a good biotech CEO? Are there unique issues to biotech and diagnostics that shape and demand a different kind of leadership?
This is a public episod…
This is a public episod…
00:26:40 |
Mon 04 Dec 2017
November 2017 with Nathan and Laura: The Stem Cell Story We’ve All Been Waiting For and a Sea Change for DTC Testing
It didn’t take long to come up with our lead story for November’s month in review show. Looking at the pictures of the boy in Germany playing soccer after successful treatment of his rare skin disea…
00:21:35 |
Fri 01 Dec 2017
Disclaimer: The podcast and artwork embedded on this page are the property of Theral Timpson. This content is not affiliated with or endorsed by eachpod.com.